
USFDA APPLICATION NUMBER - 22247 / DOSAGE - TABLET;ORAL - EQ 20MG BASE;0.45MG
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| BAZEDOXIFENE ACETATE(UNII: J70472UD3D) (BAZEDOXIFENE - UNII:Q16TT9C5BK) | BAZEDOXIFENE | 20mg |
| ESTROGENS, CONJUGATED(UNII: IU5QR144QX) (ESTROGENS, CONJUGATED - UNII:IU5QR144QX) | ESTROGENS, CONJUGATED | 0.45mg |
Inactive Ingredients
| Ingredient Name | U.S. Pharmaceuticals |
|---|---|
| ASCORBIC ACID(PQ6CK8PD0R) | |
| CELLULOSE, MICROCRYSTALLINE(OP1R32D61U) | |
| FERRIC OXIDE RED(1K09F3G675) | |
| FERRIC OXIDE YELLOW(EX438O2MRT) | |
| FERROSOFERRIC OXIDE(XM0M87F357) | |
| HYDROXYETHYL CELLULOSE (100 MPA.S AT 2%)(R33S7TK2EP) | |
| HYDROXYPROPYL CELLULOSE (TYPE H)(RFW2ET671P) | |
| HYPROMELLOSE 2208 (100000 MPA.S)(VM7F0B23ZI) | |
| ISOPROPYL ALCOHOL(ND2M416302) | |
| LACTOSE MONOHYDRATE(EWQ57Q8I5X) | |
| MAGNESIUM STEARATE(70097M6I30) | |
| MALTITOL(D65DG142WK) | |
| POLOXAMER 188(LQA7B6G8JG) | |
| POLYDEXTROSE(VH2XOU12IE) | |
| POLYETHYLENE GLYCOL 400(B697894SGQ) | |
| POVIDONES(FZ989GH94E) | |
| POWDERED CELLULOSE(SMD1X3XO9M) | |
| PROPYLENE GLYCOL(6DC9Q167V3) | |
| SUCROSE PALMITATE(3OSQ643ZK5) | |
| SUCROSE(C151H8M554) | |
| TITANIUM DIOXIDE(15FIX9V2JP) | |
| TRIBASIC CALCIUM PHOSPHATE(91D9GV0Z28) |